Neway Forms Partners with Quest Diagnostics to Expedite High-Quality ESRD Testing
Friday, October 06, 2023
Neway, LLC, a leading provider of value-based dialysis laboratory services in the United States, has announced a strategic partnership with Quest Diagnostics (NYSE: DGX) aimed at enhancing dialysis laboratory testing efficiency while simultaneously reducing costs for end-stage renal disease (ESRD) patients.
According to the terms of the agreement, Neway will leverage Quest Diagnostics' extensive network of laboratories to offer local dialysis laboratory testing services, with results typically available within one day after specimens are received at a Quest Diagnostics facility.
This collaboration between Neway and Quest represents a departure from the traditional centralized laboratory model, where the majority of U.S. dialysis programs transport specimens to a single central laboratory for processing. By utilizing Quest's distributed lab network, Neway and its affiliated dialysis centers will streamline the testing process, resulting in faster test results and reduced transportation expenses.
The conventional approach of relying on air transportation to send dialysis laboratory specimens to a single location in the U.S. has proven to be costly and time-consuming. The 'new way' of dialysis laboratory testing involves a decentralized network of laboratory locations across the nation. This innovative approach benefits dialysis patients, dialysis programs, insurance providers, and the dialysis industry as a whole. It represents a positive outcome for all parties involved.